Samsung Electronics, the world's top computer memory chip maker, said Tuesday it has signed a deal to buy a controlling stake in a top South Korean medical equipment maker.
Samsung said the deal was part of its long-term strategic expansion into the medical devices business.
It said it would acquire a 43.5 percent stake in Medison from private equity firm Consus Asset Management.
Medison is the world's fifth-largest ultrasound equipment maker, holding an estimated 6.7 percent share of the global market.
Samsung said it would also buy a 100 percent stake in Prosonic, a South Korean manufacturer of probes and cables for ultrasound devices.
It said in a statement the ultrasound diagnostics device segment is a logical entry point into the health care equipment market due to technological similarities with its existing consumer electronics and IT products.
Samsung unveiled a plan earlier this year to invest 23 trillion won (20.1 billion dollars) in new businesses, including renewable energy and health care.
Explore further: Samsung to pay Qualcomm 1.3 bln dlrs in new licensing deal